These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Theoretical aspects of the quantitative characterization of ligand binding. Sawyer WH; Winzor DJ Curr Protoc Protein Sci; 2001 May; Appendix 5():Appendix 5A. PubMed ID: 18429087 [TBL] [Abstract][Full Text] [Related]
44. The expression of recombinant human LOX-1 and identifying its mimic ligands by fluorescence polarization-based high throughput screening. Zhang T; Huang Z; Dai Y; Chen X; Zhu P; Du G J Biotechnol; 2006 Oct; 125(4):492-502. PubMed ID: 16735073 [TBL] [Abstract][Full Text] [Related]
45. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Mehta JL; Chen J; Hermonat PL; Romeo F; Novelli G Cardiovasc Res; 2006 Jan; 69(1):36-45. PubMed ID: 16324688 [TBL] [Abstract][Full Text] [Related]
46. The expression and down stream effect of lectin like-oxidized low density lipoprotein 1 (LOX-1) in hyperglycemic state. Rudijanto A Acta Med Indones; 2007; 39(1):36-43. PubMed ID: 17939209 [TBL] [Abstract][Full Text] [Related]
47. Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis? Chen XP; Zhang TT; Du GH Cardiovasc Drug Rev; 2007; 25(2):146-61. PubMed ID: 17614937 [TBL] [Abstract][Full Text] [Related]